AN AFFILIATE OF Week-in-Review: At-a-Glance

Key Highlights Other Mergers & Acquisitions Update

Tiger Global, Blackstone, NEA & Flare-backed Bright Health announces IPO at a $14 billion Valuation – Bright Health, a Acquirer Target Ent. Value health insurtech firm, is aiming for a valuation of more than $14 billion in its , according to a regulatory ($M) filing. Bright Health aims to raise over $1.3 billion by offering 60 million shares of common stock at an expected price between $20 and $23 per share. Bright Health generated over $1.2 billion in revenue in 2020 and raised $500 million in a late-stage funding round in September last year from investors such as Tiger Global Management, T. Rowe Price Associates and ND Blackstone. To date, Bright Health has raised $1.5 billion. Lyra Heath announces a $200 million funding round led by Coatue – Lyra Health, a provider of comprehensive mental ND health care benefits for employers, announced a $200M financing round led by Coatue. The funding round was joined by new investor Sands Capital. Lyra delivers mental health for employees and family members at multinational companies, including eBay, Genentech, and Uber and currently serves more than 2.2 million members globally. With the new funding, the company ND plans to accelerate the delivery of its benefits for companies with employees located around the world and enhance its international solutions. To date, Lyra Health has raised $670 million. ND Hims and Hers announces acquisition of Honest Health – Hims and Hers, a multi-specialty platform focused on providing modern personalized health and wellness experiences to all consumers, announced plans to expand their UK footprint and acquire London-based vertical health platform, Honest Health. Honest Health offers consumers hair loss-related ND products, including access to compounded products, such as a topical Finasteride with Minoxidil solution when appropriate. HealthCard The proposed transaction provides Hims & Hers with operational capability and infrastructure to support the beginnings of the ND Company’s long-term plans for expansion across the United Kingdom and Western Europe. Honest Health has received investments from companies including Fagron, VGC Partners and Founders Factory. TPG Capital and Silversmith-backed LifeStance Health IPOs at $7 billion valuation – LifeStance Health, a provider of Other Equity Financing Update outpatient mental health care, announced the closing of its initial public offering of 40,000,000 shares of common stock at a public offering price of $18.00 per share. In the offering, the Company sold 32,800,000 shares and selling stockholders sold 7,200,000 shares. Shares of the company, which is backed by private equity giant TPG Capital, were trading at $25.34 Company Lead Financing Tuesday, up 40% from the IPO price of $18 set June 9 valuating the company at more than $7 billion. Investor(s) ($M) TPG Capital-backed Convey Health IPOs at $1 billion valuation – Convey Health, a provider of technology solutions for government-sponsored health insurance plans, began trading on the NYSE Wednesday. The company announced the pricing $72 of its initial public offering of 13,333,334 shares of its common stock at a price of $14.00 per share. Convey Health plans to use the $200 million of net proceeds to repay amounts outstanding under its existing indebtedness and for general corporate purposes. The company will not receive any proceeds from the sale of shares of common stock by the selling stockholder. $34 Threshold Ventures-backed Doximity sets terms for IPO at $4.5 billion valuation – Doximity, a professional network for physicians with telehealth and scheduling tools, announced terms for its IPO. The Company plans to raise $501 million by $30 offering 23.3 million shares (18% insider) at a price range of $20 to $23. At the midpoint of the proposed range, the Company would have a fully diluted market value of $4.5 billion. Doximity is an online platform for physicians to collaborate with colleagues, securely coordinate patient care, and conduct virtual patients visits. Doximity booked $207 million in sales for the $21 12 months ended March 31, 2021. To date, Doximity has raised $82 million from investors including Threshold Ventures, T. Rowe Price, Morgenthaler Ventures, and Emergence Capital Partners. The Pill Club announces a $42 million Series B led by Base 10 – The Pill Club, an online birth control prescription and $9 delivery service, announced a $42 million series B led by Base 10 with participation from GV, Shasta Ventures, iGlobe and VMG. After filling out a questionnaire, the Company connects customers virtually to a nurse either via live video or text. The $5 Pill Club recently crossed $100 million of run rate revenue. To date, The Pill Club has raised $117 million. Healthcare Technology & Tech-Enabled Services Weekly Performance Market Leaders Market Laggards

18.7% 17.6% 15.4% 11.1% 8.9% (25.2%) (12.4%) (9.4%) (7.4%) (3.9%)

Private and Source: Capital IQ, public filings and news. Confidential 2 Week-in-Review: Healthcare Technology & Tech-Enabled Services Stock Performance as June 17, 2021

Year-to-Date 1-Month

85% 77% 35% 30% 69% 25% 48% 21% 39% 21% 37% 20% 27% 17% 60% 26% 16% 16% 24% 25% 24% 14% 24% 13% 23% 13% 23% 12% 35% 22% 12% 21% 12% 19% 11% 15% 15% 10% 14% 9% 14% 7% 10% 13% 5% 12% 4% 12% 3% 7% 2% 1% 5% 2% (1%) 1% (1%) (15%) 1% (2%) 1% (3%) 0% (6%) (0%) (8%) (1%) (8%) (5%) (1%) (10%) (40%) (3%) (14%) (3%) (17%) (3%) (22%) (4%) (23%) (4%) (28%) (5%) (46%) (9%) (65%) (15%) 1/1 1/22 2/12 3/5 3/26 4/16 5/7 5/28 5/17 5/22 5/27 6/1 6/6 6/11 6/16 Private and Source: Capital IQ. Companies whose IPO was in 2020 represent performance since list price on Form 424B4. Confidential 3 Week-in-Review: Industry and Company News

Industry and Company News Industry and Company News (Cont’d)

Supreme Court upholds ACA, dismissing constitutional challenge Payers focus on artificial intelligence and machine learning • “In a 7-2 opinion delivered Thursday, the Supreme Court tossed out a constitutional challenge • “COVID-19 has led to an increase in payer adoption of technology and innovation, according to the Affordable Care Act, leaving the law intact. Seven justices of the court, which now has a to Shreesh Tiwari, principal at ZS, speaking during the HIMSS State of Healthcare event. 6-3 conservative majority, concluded that the plaintiffs “failed to show that they have standing Sixty-four percent of health insurance executives report an accelerated adoption of digital to attack as unconstitutional the Act’s minimum essential coverage provision.” This means the health initiatives such as virtual health. Another 53% report an acceleration in adoption of plaintiffs, including the state of Texas, were not able to prove that they had been harmed by artificial intelligence and machine learning practices, while 42% said COVID-19 has helped the law. The plaintiffs’ arguments stemmed from Congress’s decision in 2017 to reduce the facilitate the adoption of value-based care arrangements, according to State of Healthcare penalty for not obtaining a minimum level of healthcare coverage - as mandated by the law - to research by HIMSS, the parent company of Healthcare Finance News. COVID-19 has helped $0. Texas, 17 other states and two individuals brought a lawsuit claiming that with a $0 to drive changes not just in technology, but in attitude, Tiwari said. The mental and cultural penalty, the requirement is unconstitutional as it can no longer be considered a tax. They barriers in terms of adoption are no longer being seen as issues. Around half of payers have further argued that the requirement cannot be severed from the rest of the act, and hence, the an innovation lab and believe AI and machine learning will drive innovation forward. But 53% act as a whole is invalid. Though the long-awaited decision did not address the larger question believe healthcare startups will lead the way in driving big technology innovation, Tiwari said. of whether the minimum essential coverage requirement can be severed from the law, it The government also plays a key role. Forty-six percent of payers think current policies and effectively ends another major challenge to former President Barrack Obama’s signature regulations will facilitate innovation.” Healthcare Finance News | 6/17/21 legislation.” MedCity News | 6/17/21 joins CivicaScript initiative to lower the cost of certain generic Apple's new health data sharing feature is part of the patient-controlled drugs data trend • “Civica Rx, the non-profit organization founded in 2018 by health systems Intermountain, the Mayo Clinic, Providence St. Joseph Health and others to address generic drug shortages and this week, Apple announced a new health sharing feature that gives patients the reins • “Earlier high costs, has announced the addition of Anthem to its initiative. Anthem is joining Civica Rx's in sharing consumer-generated health data with their doctors, family and friends. Apple has operating unit, CivicaScript, as a new health insurer partner, joining the entity's co-founders, been working on giving patients more access to their data for years. In 2018, the company the Blue Cross Blue Shield Association and 17 independent and locally-operated Blue Cross rolled out Health Records on iOS, which aggregates existing user-generated data in their and Blue Shield companies. Combined, CivicaScript partners represent close to 100 million Health app with data from their EHR if the user is a patient at a participating hospital. This – lives, the organization said. While many generic medicines cost less than brand name drugs, new feature turns the tables instead of patients accessing medical data generated by the – some high-cost generics are more expensive due to lack of competition in the market. Generic health system, the patient is in the driver's seat, sharing their own information. This information medicines account for nearly 90% of all prescriptions. Numerous studies confirm that includes everything from mobility trends to heart data. Additionally, users are able to share lab medication costs can dictate whether patients fill or ration their generic prescriptions. results with those of their choosing. When it comes to sharing the data, it's not an all-or- CivicaScript has the goal of lowering the cost of select high-cost generic medications. It will nothing approach. Users are able to pick and choose what data points they share with whom. initially develop and manufacture six to 10 common but high-priced generic medicines for For example, users may share their labs with their children, but not their mobility data .” which there is currently not enough market competition to drive down price, Civica said MobiHealth News | 6/11/21 .” Healthcare Finance News | 6/16/21 Patients are looking to go back to brick-and-mortar post pandemic More details emerge about Facebook's potential wearable • “While half of patients have experienced a telehealth visit in the last year, the bulk of them say • “More information has emerged about Facebook's potential new wearable. According to The they want to get back to normal in-person visits, according to new research conducted by Verge, the social media company is developing a new smartwatch that includes two cameras, HIMSS. In fact, HIMSS' State of Healthcare report found that 60% of patients want to return to which customers can use to upload photos to social media. Rumors of a potential wearable their pre-pandemic experiences. The new research included 2,062 participants and was have been circulating since at least February when The Information cited four anonymous conducted during March and April 2021. In order to be included, participants had to have at Facebook sources claiming a watch was in the works. The wearable is also expected to have least one medical visit within the last 12 months. The research found that Gen Z and at least one health feature: a heart rate monitor. Verge sources report that the Palo Alto Millennials were the most likely to be open to telehealth, with 47% of millennials saying they company invested $1 billion to develop the watch and compete with Apple and Google. The would prefer telehealth over in-person visits once the pandemic has ended. Nearly three- new information was in line with previous reports that the device will include a cellular quarters of younger generations reported that one reason they prefer telehealth is connection and doesn't need to be tethered to a smartphone. The tool is expected to cost in convenience. The silent generation and the Baby Boomers were the least likely to favor in- the $400 range with an expected Summer 2022 release.” MobiHealth News | 6/10/21 person visits over telehealth.” MobiHealth News | 6/15/21

Private and Source: Public information. Confidential 4 Stock Price Performance & Valuation

Private and Confidential 5 Healthcare Technology & Tech-Enabled Services

Price Stock Price Performance Equity Enterprise Revenue % Rev Growth EV / Revenue EBITDA Margin EV / EBITDA Price / EPS Company Name 6/17/21 Weekly 1-Month 3-Month 6-Month LTM YTD Value Value CY2020 CY2021 CY2022 CY2020 CY2021 CY2020 CY2021 CY2020 CY2021 CY2020 CY2021 Payer-Tech Change Healthcare $23.07 (2.0%) 1.0% (0.4%) 26.1% 93.4% 23.7% $7,155 $11,827 $3,030 12.2% 7.0% 3.9 x 3.5 x 28.6% 30.5% 13.6 x 11.4 x 21.2 x 14.8 x Convey Health $12.64 IPO IPO IPO IPO IPO IPO $923 $1,213 $283 NA NA 4.3 x NA NA NA NA NA NA NA eHealth 61.00 (1.0%) (2.9%) (4.6%) (16.0%) (43.5%) (13.6%) 1,594 1,468 583 18.5% 23.6% 2.5 x 2.1 x 14.1% 16.9% 17.8 x 12.6 x 25.4 x 21.0 x GoHealth 11.32 (0.5%) 1.0% (2.8%) (20.5%) IPO (17.1%) 1,132 2,310 877 40.0% 26.9% 2.6 x 1.9 x 32.0% 29.8% 8.2 x 6.3 x 24.9 x 15.9 x Inovalon 32.17 (1.2%) 4.0% 16.9% 66.4% 69.6% 77.1% 5,015 5,858 668 14.5% 12.5% 8.8 x 7.7 x 34.5% 35.4% 25.4 x 21.6 x 53.6 x 42.9 x ModivCare 165.51 2.3% 14.6% 14.9% 21.9% 108.1% 19.4% 2,320 2,507 1,369 45.6% 9.0% 1.8 x 1.3 x 12.2% 8.6% 15.0 x 14.6 x 22.9 x 27.4 x MultiPlan Corporation 9.10 2.2% 18.5% 46.1% (2.8%) IPO 13.9% 5,995 10,740 938 12.7% 6.0% 11.5 x 10.2 x 75.3% 74.5% 15.2 x 13.6 x NA 58.6 x Nuance Communications 54.64 (0.6%) 4.0% 21.5% 26.4% 136.2% 23.9% 15,632 16,777 1,355 2.9% 9.8% 12.4 x 12.0 x 24.1% 28.9% NM 41.6 x NM 71.9 x Ontrak 34.90 8.9% 10.0% (4.0%) (47.5%) 64.8% (43.5%) 619 574 83 1.3% 46.4% 6.9 x 6.8 x NM NM NM NM NM NM Tabula Rasa HealthCare 49.16 17.6% 21.2% 2.3% 23.5% (13.8%) 14.8% 1,221 1,550 297 15.7% 17.2% 5.2 x 4.5 x 7.3% 8.4% NM NM NM NM Tivity Health 27.14 0.5% 11.1% 13.3% 43.5% 159.7% 38.5% 1,336 1,719 438 8.4% 16.5% 3.9 x 3.6 x 50.0% 32.3% 7.9 x 11.2 x 15.9 x 17.7 x Mean 2.6% 8.3% 10.3% 12.1% 71.8% 13.7% 17.2% 17.5% 5.8 x 5.4 x 30.9% 29.5% 14.7 x 16.6 x 27.3 x 33.8 x Median (0.0%) 7.0% 7.8% 22.7% 81.5% 17.1% 13.6% 14.5% 4.3 x 4.1 x 28.6% 29.8% 15.0 x 13.1 x 23.9 x 24.2 x

Employer-Health Tech Accolade $53.35 (0.2%) 26.6% 12.9% 3.0% IPO 22.6% $3,130 $2,696 $156 53.4% 31.1% 17.3 x 11.3 x NM NM NM NM NA NM Benefitfocus 14.27 3.9% 0.4% (1.9%) (0.3%) 28.7% (1.5%) 473 551 268 (4.0%) 3.2% 2.1 x 2.1 x 14.1% 18.6% 14.5 x 11.5 x NM NM Castlight Health 2.20 11.1% 24.3% 22.2% 76.0% 169.7% 69.2% 347 292 147 (5.8%) 4.4% 2.0 x 2.1 x 5.5% 4.6% 36.0 x 45.6 x NM NA HealthEquity 78.31 0.4% 2.3% 6.7% 19.5% 28.0% 12.3% 6,530 6,766 734 3.7% 9.5% 9.2 x 8.9 x 32.5% 32.2% 28.4 x 27.6 x 46.6 x 52.7 x Limeade, Inc. 0.62 7.9% 35.5% (3.5%) (46.4%) (39.3%) (47.1%) 155 124 57 (9.3%) 10.1% 2.2 x 2.4 x NM NM NM NM NM NM Progyny 62.88 (1.8%) 19.8% 29.0% 57.6% 178.8% 48.3% 5,566 5,460 345 55.8% 44.3% 15.8 x 10.2 x 8.8% 13.7% NM NM NM NM Mean 3.6% 18.2% 10.9% 18.2% 73.2% 17.3% 15.6% 17.1% 8.1 x 6.2 x 15.2% 17.3% 26.3 x 28.2 x 46.6 x 52.7 x Median 2.2% 22.0% 9.8% 11.3% 28.7% 17.5% (0.2%) 9.8% 5.7 x 5.7 x 11.4% 16.1% 28.4 x 27.6 x 46.6 x 52.7 x

Provider-Tech Allscripts $17.72 (1.8%) 4.0% 13.7% 24.0% 157.4% 22.7% $2,501 $2,157 $1,503 (0.1%) 2.6% 1.4 x 1.4 x 19.6% 17.0% 7.3 x 8.4 x 26.1 x 24.3 x Corporation 78.93 (2.7%) 3.2% 9.2% 1.0% 13.4% 0.6% 23,783 24,176 5,506 5.4% 5.6% 4.4 x 4.2 x 31.6% 32.7% 13.9 x 12.8 x 27.8 x 24.6 x CPSi 33.74 0.4% 5.0% 3.9% 21.8% 50.6% 25.7% 487 540 264 6.7% 6.9% 2.0 x 1.9 x 16.8% 17.8% 12.1 x 10.7 x 14.2 x 13.1 x Craneware 30.73 4.0% (13.5%) (2.4%) (2.0%) 27.5% (4.1%) 1,015 965 74 5.6% 7.4% 13.1 x 12.4 x 35.0% 35.1% 37.5 x 35.4 x 48.2 x 44.8 x Flywire 32.44 15.4% IPO IPO IPO IPO IPO 3,294 3,465 132 NA NA NM NA NA NA NA NA NA NA Health Catalyst 55.43 (3.9%) 17.5% 14.4% 31.7% 86.7% 27.3% 2,468 2,373 189 22.3% 21.1% 12.6 x 10.3 x NM NM NM NM NM NM HealthStream 26.66 0.6% 3.3% 15.9% 26.5% 23.3% 22.1% 841 785 245 2.5% 7.6% 3.2 x 3.1 x 18.0% 17.3% 17.8 x 18.1 x 73.0 x NM NextGen Healthcare 17.69 2.8% (3.7%) (11.8%) (6.6%) 65.6% (3.0%) 1,186 1,112 549 4.0% 3.9% 2.0 x 1.9 x 16.7% 18.3% 12.1 x 10.6 x 24.4 x 20.1 x NantHealth 2.65 (0.7%) 5.6% (28.0%) (5.7%) (26.2%) (18.0%) 301 509 73 (4.1%) 9.2% 7.0 x 7.2 x NA NA NA NA NM NM NRC Health 44.57 0.9% (9.0%) (11.5%) (6.8%) (18.2%) 4.3% 1,133 1,121 133 NA NA 8.4 x NA NA NA NA NA NA NA Phreesia 58.21 1.4% 31.0% (0.1%) 1.3% 100.5% 7.3% 2,941 2,500 149 29.8% 21.4% 16.8 x 13.0 x 3.2% 0.5% NM NM NM NM Premier 34.52 1.8% 1.5% 1.5% (2.2%) 1.3% (1.7%) 4,221 4,716 1,447 14.1% (13.3%) 3.3 x 2.9 x 33.2% 28.1% 9.8 x 10.2 x 14.8 x 14.7 x Privia 43.18 8.7% 45.3% IPO IPO IPO IPO 4,565 4,514 817 7.0% 12.9% 5.5 x 5.2 x NA 4.1% NA NM NA NM Omnicell 145.29 3.5% 10.1% 1.0% 25.3% 109.1% 21.1% 6,275 6,199 892 23.4% 12.6% 6.9 x 5.6 x 17.7% 21.7% 39.2 x 25.9 x 58.3 x 40.2 x R1 RCM 22.06 (0.0%) (8.4%) (15.7%) (3.1%) 94.0% (8.2%) 6,098 6,541 1,271 14.1% 16.6% 5.1 x 4.5 x 18.5% 22.7% 27.9 x 19.9 x NM 55.8 x Vocera Communications 37.26 0.5% 13.9% (7.5%) (1.1%) 86.1% (10.3%) 1,281 1,201 198 13.4% 13.5% 6.1 x 5.3 x 13.8% 13.2% 43.8 x 40.5 x NM 65.9 x WELL Health 6.46 1.7% 16.0% (1.0%) 10.7% 191.9% (1.0%) 1,264 1,216 67 223.5% 60.5% 18.2 x 5.6 x NM 19.4% NM 29.0 x NM NM Mean 1.9% 7.6% (1.2%) 7.6% 64.2% 5.7% 24.5% 12.6% 7.3 x 5.6 x 20.4% 19.1% 22.1 x 20.1 x 35.8 x 33.7 x Median 0.9% 4.5% (0.1%) 1.0% 65.6% 0.6% 7.0% 9.2% 5.8 x 5.2 x 18.0% 18.3% 15.9 x 18.1 x 26.9 x 24.6 x

Source: Capital IQ and Public filings. Note: Revenue, EBITDA, P/E multiples and EBITDA margins denoted as 'NM' if negative, or greater than 25.0x, 50.0x and 75.0x, respectively. Private and Enterprise Value includes non-controlling interest and preferred equity. Amounts presented in USD, Millions Except Per Share data. Confidential 6 Healthcare Technology & Tech-Enabled Services (Cont’d)

Price Stock Price Performance Equity Enterprise Revenue % Rev Growth EV / Revenue EBITDA Margin EV / EBITDA Price / EPS Company Name 6/17/21 Weekly 1-Month 3-Month 6-Month LTM YTD Value Value CY2020 CY2021 CY2022 CY2020 CY2021 CY2020 CY2021 CY2020 CY2021 CY2020 CY2021 Pharma-Tech Certara $27.53 1.4% 11.1% (12.6%) (29.9%) IPO (18.4%) $4,212 $4,240 $244 15.5% 15.2% 17.4 x 15.1 x 35.9% 35.9% 48.5 x 41.9 x NM NM IQVIA $246.30 1.4% 6.4% 29.8% 37.6% 77.3% 37.5% $47,206 $57,368 $11,359 18.4% 8.1% 5.1 x 4.3 x 20.7% 21.9% 24.4 x 19.5 x 39.0 x 28.3 x OptimizeRx 53.65 5.2% 22.7% 2.7% 80.6% 302.5% 72.2% 927 845 43 34.7% 25.9% 19.5 x 14.5 x 3.5% 15.5% NM NM NM NM Veeva Systems 305.36 3.5% 23.2% 17.7% 9.1% 33.4% 12.2% 46,695 44,545 1,465 24.4% 19.0% NM 24.4 x 40.8% 40.4% NM NM NM NM Mean 2.9% 15.8% 9.4% 24.4% 137.7% 25.9% 23.2% 17.0% 14.0 x 14.6 x 25.2% 28.4% 36.5 x 30.7 x 39.0 x 28.3 x Median 2.5% 16.9% 10.2% 23.4% 77.3% 24.8% 21.4% 17.1% 17.4 x 14.8 x 28.3% 28.9% 36.5 x 30.7 x 39.0 x 28.3 x

Virtual Care-Tech 23andMe $13.32 IPO IPO IPO IPO IPO IPO -- -- NA NA NA NA NA NA NA NA NA NA NA American Well $13.71 (1.9%) 14.4% (34.8%) (51.6%) IPO (45.9%) $3,305 $2,330 $245 7.9% 26.9% 9.5 x 8.8 x NM NM NM NM NM NM Dialogue Health 9.74 (1.2%) (8.3%) IPO IPO IPO IPO 646 544 29 103.1% 44.0% 18.8 x 9.2 x NA NM NA NM NA NM GoodRx 37.89 2.2% 24.6% 1.3% (17.0%) IPO (6.1%) 14,889 14,564 551 36.1% 39.3% NM 19.4 x 36.2% 31.5% NM NM NM NM Hims & Hers 11.64 (9.4%) 26.4% (25.5%) IPO IPO IPO 2,233 1,909 149 51.0% 26.2% 12.8 x 8.5